| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Essa Pharma, Inc.
13G/A
EPIX · 29668H708
|
5.1% |
2/11/2025
Event 12/31/2024
|
||||
| Soleus Capital Special Opportunities Fund, L.P. | 0% | |||||
| Soleus Capital Master Fund, L.P. | 5.1% | |||||
| Soleus Capital, LLC | 5.1% | |||||
| Soleus Capital Group, LLC | 5.1% | |||||
| Soleus Capital Management, L.P. | 5.1% | |||||
| Soleus GP LLC | 5.1% | |||||
| Guy Levy | 5.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.